Population Pharmacokinetics and Dosing Simulations for Paliperidone Palmitate 351 mg as Alternative Maintenance Doses in Patients With Schizophrenia or Schizoaffective Disorder
The Journal of Clinical Psychiatry · 2026
DOI: 10.4088/jcp.26m16416 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, 2026. Verfasst von Yonglin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Luye Pharma (USA), Ltd., Princeton, New Jersey. Hauptthemen laut MEDLINE: Antipsychotic Agents, Paliperidone Palmitate, Psychotic Disorders, Schizophrenia.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Luye Pharma (USA), Ltd., Princeton, New Jersey.
- JP Global Pharma LLC, Rockville, Maryland.
- University of California San Diego, La Jolla, California.
- New York Medical College, Valhalla, New York.
- Luye Pharmaceutical Research & Development Center, Luye Pharma Group, Ltd., Yantai, Shandong, China.
- Corresponding Author: Ying Dong, MD, PhD, Luye Pharma (USA), Ltd., 502 Carnegie Center, Suite 100, Princeton, NJ 08540 (ying.dong@luye.com).
Zitieren
APA
Chen, Y., Hu, L., Meyer, J. M., Citrome, L., Song, H., Wang, S., Liu, P., Yang, J. J., & Dong, Y. (2026). Population Pharmacokinetics and Dosing Simulations for Paliperidone Palmitate 351 mg as Alternative Maintenance Doses in Patients With Schizophrenia or Schizoaffective Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.26m16416
Vancouver
Chen Y, Hu L, Meyer JM, Citrome L, Song H, Wang S, et al. Population Pharmacokinetics and Dosing Simulations for Paliperidone Palmitate 351 mg as Alternative Maintenance Doses in Patients With Schizophrenia or Schizoaffective Disorder. The Journal of Clinical Psychiatry. 2026. doi:10.4088/jcp.26m16416
BibTeX
@article{Chen2026,
author = {Chen, Yonglin and Hu, Leijun and Meyer, Jonathan M and Citrome, Leslie and Song, Hongtao and Wang, Siwen and Liu, Pinglan and Yang, John J and Dong, Ying},
title = {Population Pharmacokinetics and Dosing Simulations for Paliperidone Palmitate 351 mg as Alternative Maintenance Doses in Patients With Schizophrenia or Schizoaffective Disorder},
journal = {The Journal of Clinical Psychiatry},
year = {2026},
doi = {10.4088/jcp.26m16416}
}
EUVIMED